Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by O. Goldblum
541 Evaluation of Optimal Psoriasis Assessment Tool (OPAT) Incorporating Both Clinical and Patient-Reported Outcomes for Treatment of Moderate-To-Severe Plaque Psoriasis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Related publications
Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
Patient-Reported Reasons for the Discontinuation of Commonly Used Treatments for Moderate to Severe Psoriasis
Journal of the American Academy of Dermatology
Dermatology
Psy149 - Iqvia Patient Data Assessment: Real World Evidence in the Management of Moderate-To-Severe Plaque Psoriasis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pss32 - Cost-Effectiveness of Brodalumab for the Treatment of Moderate to Severe Plaque Psoriasis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Population Pharmacokinetics of Brodalumab in Patients With Moderate to Severe Plaque Psoriasis
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Safety, Efficacy, and Drug Survival of Biologics and Biosimilars for Moderate-To-Severe Plaque Psoriasis
British Journal of Dermatology
Dermatology
Medicine
Spotlight on Ixekizumab for the Treatment of Moderate-To-Severe Plaque Psoriasis: Design, Development, and Use in Therapy
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
The Experience of Pain and Redness in Patients With Moderate to Severe Plaque Psoriasis
Journal of Dermatological Treatment
Dermatology
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
JAMA Dermatology
Dermatology
Medicine